Ultragenyx Seeks An FDA Win For Biologic Therapy Candidate By: Benzinga via Benzinga November 15, 2017 at 07:36 AM EST After Heron Therapeutics Inc (NASDAQ: HRTX), Bristol-Myers Squibb Co (NYSE: BMY) and Dynavax Technologies Corporation (NASDAQ: ... Read More >> Related Stocks: Bristol-Myers Squibb Dynavax Technologies Ultragenyx Pharmaceu